Us Physicalrapy Stock Total Debt
| USPH Stock | USD 98.02 0.19 0.19% |
US Physicalrapy fundamentals help investors to digest information that contributes to US Physicalrapy's financial success or failures. It also enables traders to predict the movement of USPH Stock. The fundamental analysis module provides a way to measure US Physicalrapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to US Physicalrapy stock.
The US Physicalrapy's current Total Debt To Capitalization is estimated to increase to 0.28. USPH | Total Debt |
US Physicalrapy Company Total Debt Analysis
US Physicalrapy's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current US Physicalrapy Total Debt | 258.59 M |
Most of US Physicalrapy's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, US Physicalrapy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
USPH Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for US Physicalrapy is extremely important. It helps to project a fair market value of USPH Stock properly, considering its historical fundamentals such as Total Debt. Since US Physicalrapy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of US Physicalrapy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of US Physicalrapy's interrelated accounts and indicators.
Click cells to compare fundamentals
USPH Total Debt Historical Pattern
Today, most investors in US Physicalrapy Stock are looking for potential investment opportunities by analyzing not only static indicators but also various US Physicalrapy's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of US Physicalrapy total debt as a starting point in their analysis.
US Physicalrapy Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
USPH Net Debt
Net Debt |
|
Based on the latest financial disclosure, US Physicalrapy has a Total Debt of 258.59 M. This is 90.6% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 95.14% higher than that of the company.
USPH Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Physicalrapy's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics of similar companies.US Physicalrapy is currently under evaluation in total debt category among its peers.
US Physicalrapy ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, US Physicalrapy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to US Physicalrapy's managers, analysts, and investors.Environmental | Governance | Social |
US Physicalrapy Institutional Holders
Institutional Holdings refers to the ownership stake in US Physicalrapy that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of US Physicalrapy's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing US Physicalrapy's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 343.1 K | Riverbridge Partners Llc | 2024-09-30 | 336.1 K | Gw&k Investment Management, Llc | 2024-09-30 | 320 K | Envestnet Asset Management Inc | 2024-09-30 | 249.6 K | Northern Trust Corp | 2024-09-30 | 229.8 K | Fred Alger Management, Llc | 2024-09-30 | 172.3 K | Fmr Inc | 2024-09-30 | 164.5 K | Bank Of New York Mellon Corp | 2024-06-30 | 157.1 K | Bank Of America Corp | 2024-06-30 | 150.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.4 M | Blackrock Inc | 2024-06-30 | 2.3 M |
USPH Fundamentals
| Return On Equity | 0.0475 | ||||
| Return On Asset | 0.0424 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 1.61 B | ||||
| Shares Outstanding | 15.1 M | ||||
| Shares Owned By Insiders | 1.58 % | ||||
| Shares Owned By Institutions | 98.42 % | ||||
| Number Of Shares Shorted | 597.87 K | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 3.06 X | ||||
| Price To Sales | 2.31 X | ||||
| Revenue | 604.8 M | ||||
| Gross Profit | 112.02 M | ||||
| EBITDA | 74.37 M | ||||
| Net Income | 37.22 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 258.59 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 32.02 X | ||||
| Cash Flow From Operations | 81.98 M | ||||
| Short Ratio | 6.03 X | ||||
| Earnings Per Share | 0.88 X | ||||
| Price To Earnings To Growth | 3.88 X | ||||
| Target Price | 107.4 | ||||
| Number Of Employees | 3.9 K | ||||
| Beta | 1.39 | ||||
| Market Capitalization | 1.48 B | ||||
| Total Asset | 997.24 M | ||||
| Retained Earnings | 223.77 M | ||||
| Working Capital | 131.19 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.01 % | ||||
| Net Asset | 997.24 M | ||||
| Last Dividend Paid | 1.75 |
About US Physicalrapy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:Check out US Physicalrapy Piotroski F Score and US Physicalrapy Altman Z Score analysis. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 1.75 | Earnings Share 0.88 | Revenue Per Share 42.489 | Quarterly Revenue Growth 0.12 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.